Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,304 | 73,551 | 256,965 | 187,661 | 39,904 |
| Marketable Securities | 122,882 | 136,793 | 7,250 | N/A | N/A |
| Receivables | 3,977 | 2,416 | 3,530 | 4,713 | 3,633 |
| Other current assets | 17,380 | 35,036 | 3,061 | 1,534 | 1,647 |
| TOTAL | $224,543 | $247,796 | $270,806 | $193,908 | $45,184 |
| Non-Current Assets | |||||
| PPE Net | 37,344 | 38,501 | 15,049 | 3,397 | 4,265 |
| Investments And Advances | 783 | 782 | 647 | 0 | 0 |
| Intangibles | 6,642 | 5,891 | 5,042 | 4,913 | 4,764 |
| Other Non-Current Assets | 4,470 | 2,063 | 25 | 2,775 | 155 |
| TOTAL | $49,239 | $47,237 | $20,763 | $11,085 | $9,184 |
| Total Assets | $273,782 | $295,033 | $291,569 | $204,993 | $54,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,936 | 98 | 92 | 89 | 85 |
| Accounts payable and accrued liabilities | 20,234 | 12,408 | 8,080 | 7,532 | 9,396 |
| Accrued Expenses | 29,053 | 17,366 | 14,601 | 2,741 | 2,244 |
| Other current liabilities | 1,275 | 1,185 | 9,894 | 65,220 | 5,572 |
| TOTAL | $62,294 | $36,867 | $35,966 | $78,886 | $20,601 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,969 | 3,738 | 1,576 | 1,668 | 1,757 |
| Deferred Revenues | 3,303 | 3,318 | 3,299 | 3,304 | 3,304 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 993 |
| TOTAL | $21,141 | $10,513 | $8,411 | $2,428 | $2,750 |
| Total Liabilities | $83,435 | $47,380 | $44,377 | $81,314 | $23,351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,666 | 41,312 | 37,775 | 31,831 | 22,628 |
| Common Shares | 5 | 4 | 4 | 3 | 2 |
| Retained earnings | -899,055 | -679,025 | -543,236 | -431,251 | -309,964 |
| Other shareholders' equity | -111 | -95 | 0 | 0 | 0 |
| TOTAL | $190,347 | $247,653 | $247,192 | $123,679 | $31,017 |
| Total Liabilities And Equity | $273,782 | $295,033 | $291,569 | $204,993 | $54,368 |